ID
37324
Descripción
Study ID: 111592 Clinical Study ID: 111592 Study Title: A Randomized, Double-blind, Placebo-controlled, Doseescalation Study to Assess the Anti-inflammatory Activity, Efficacy, and Safety of Intravenous SB-681323 in Subjects at Risk for Development of Acute Lung Injury or ARDS Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00996840 See https://clinicaltrials.gov/ct2/show/NCT00996840 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 2 Study Recruitment Status: Completed Generic Name: Placebo, SB-681323 Trade Name: N/A Study Indication: Lung Injury, Acute The primary objective of this phase 2 trial is to evaluate the safety and tolerability of intravenous dilmapimod/SB-681323 given in escalating dosages and over different intervals for three days in trauma patients at risk for the development of ALI or ARDS. This study consists of Screening, infusion of dilmapimod/SB-681323 on days 1-3, examination/sampling up to early day 5 (denoted as "Day 3 - 48 hrs") and a Follow-up on day 7. There are four cohorts, cohorts 1 and 3 receive the medication (or placebo) infusion over 4 hours, cohorts 2 and 4 over 24 hours. This 12 lead ECG form is to be completed at Screening, Day 2/3/4 at 0 hrs for all cohorts (Day 4 0 hrs denoted as Day 3 24 hrs), Follow-Up and for any repeat/unscheduled ECGs.
Link
https://clinicaltrials.gov/ct2/show/NCT00996840
Palabras clave
Versiones (1)
- 17/7/19 17/7/19 -
Titular de derechos de autor
GlaxoSmithKline
Subido en
17 de julio de 2019
DOI
Para solicitar uno, por favor iniciar sesión.
Licencia
Creative Commons BY-NC 3.0
Comentarios del modelo :
Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.
Comentarios de grupo de elementos para :
Comentarios del elemento para :
Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.
SB-681323 in ALI/ARDS risk patients - NCT00996840
12 Lead ECG
- StudyEvent: ODM
Descripción
Dosing Date and Time
Alias
- UMLS CUI-1
- C3897500
- UMLS CUI-2
- C3469597
- UMLS CUI-3
- C0304229
Descripción
ECG
Alias
- UMLS CUI-1
- C1623258
Descripción
only applicable for scheduled ECGs on Day 2 (0 hrs) and Day 3 (0 hrs, 24 hrs)
Tipo de datos
integer
Alias
- UMLS CUI [1,1]
- C0439564
- UMLS CUI [1,2]
- C0687676
- UMLS CUI [1,3]
- C3897500
- UMLS CUI [1,4]
- C3469597
- UMLS CUI [1,5]
- C0304229
Descripción
ECG Date / Time
Tipo de datos
datetime
Alias
- UMLS CUI [1]
- C2826846
Descripción
Heart Rate
Tipo de datos
integer
Unidades de medida
- beats/min
Alias
- UMLS CUI [1]
- C0018810
Descripción
PR Interval
Tipo de datos
float
Unidades de medida
- msec
Alias
- UMLS CUI [1]
- C0429087
Descripción
QRS Duration
Tipo de datos
float
Unidades de medida
- msec
Alias
- UMLS CUI [1]
- C0429025
Descripción
Uncorrected QT Interval
Tipo de datos
float
Unidades de medida
- msec
Alias
- UMLS CUI [1,1]
- C1287082
- UMLS CUI [1,2]
- C4072785
Descripción
If Machine -> record the QTC values(s) generated by the machine (QTcF/QTcB) If Manual -> record the RR interval that precedes the measured QT interval
Tipo de datos
integer
Alias
- UMLS CUI [1,1]
- C0855331
- UMLS CUI [1,2]
- C2911685
Descripción
if applicable
Tipo de datos
float
Unidades de medida
- msec
Alias
- UMLS CUI [1,1]
- C1882512
- UMLS CUI [1,2]
- C0855331
Descripción
if applicable
Tipo de datos
float
Unidades de medida
- msec
Alias
- UMLS CUI [1,1]
- C0855331
- UMLS CUI [1,2]
- C1882513
Descripción
if applicable
Tipo de datos
float
Unidades de medida
- msec
Alias
- UMLS CUI [1,1]
- C0489636
- UMLS CUI [1,2]
- C0332152
- UMLS CUI [1,3]
- C0855331
Descripción
if 3 = Abnormal - Clinically significant: complete the ECG abnormality form for all clinically significant abnormalities, and additionally complete the AE form if the abnormality meets the protocol definition for an AE
Tipo de datos
integer
Alias
- UMLS CUI [1]
- C0438154
Similar models
12 Lead ECG
- StudyEvent: ODM
C3469597 (UMLS CUI-2)
C0304229 (UMLS CUI-3)
C3469597 (UMLS CUI [1,2])
C0304229 (UMLS CUI [1,3])
C0687676 (UMLS CUI [1,2])
C3897500 (UMLS CUI [1,3])
C3469597 (UMLS CUI [1,4])
C0304229 (UMLS CUI [1,5])
C4072785 (UMLS CUI [1,2])
C2911685 (UMLS CUI [1,2])
C0855331 (UMLS CUI [1,2])
C1882513 (UMLS CUI [1,2])
C0332152 (UMLS CUI [1,2])
C0855331 (UMLS CUI [1,3])
Sin comentarios